M. Averna

发表论文 35 篇 · 总被引 1805 次 · h-index 16

代表论文

• EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. (2020 · European Journal of Preventive Cardiology · 被引 720)
• 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance (2023 · European Heart Journal · 被引 315)
• Guidance for the diagnosis and treatment of hypolipidemia disorders. (2022 · Journal of Clinical Lipidology · 被引 62)
• Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study (2020 · Journal of Internal Medicine · 被引 32)
• Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023 · Atherosclerosis · 被引 30)
• Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries (2023 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · 被引 25)